Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
- 21 May 2010
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 23 (8) , 1104-1112
- https://doi.org/10.1038/modpathol.2010.95
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid TumorsCancer Research, 2009
- Intraepithelial T cells and tumor proliferationCancer, 2009
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 lossLaboratory Investigation, 2009
- Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell CarcinomaClinical Cancer Research, 2008
- Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinomaHuman Pathology, 2008
- Histologic Subtypes of Ovarian CarcinomaInternational Journal of Gynecological Pathology, 2008
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeProceedings of the National Academy of Sciences, 2007
- B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltrationGynecologic Oncology, 2007
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- An Address System in the Vasculature of Normal Tissues and TumorsAnnual Review of Immunology, 2000